No Data
No Data
Willow Biosciences Narrows Q3 Loss, Raises Guidance
Willow Biosciences Announces Second Program With Global Ingredient Manufacturer
Willow Biosciences Announces Commercial License and Royalty Agreement With Kalsec
Willow Biosciences Brief: Announcing Commercial License and Royalty Agreement With Kalsec Inc.
Willow Biosciences CEO Confident in Future After Record Revenue and New Partnerships - ICYMI | TSX:WLLW, OTCQB:CANSF
Willow Biosciences Reports Record Revenue Growth and Strategic Advances in Q2 2024 | TSX:WLLW, OTCQB:CANSF